TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/18/21 16:45 | 5/14/21 | GMTX | Gemini Therapeutics, Inc. /de | DE | Health | Drug | Pharmaceutical Preparations | Meyenburg Jason Patrick | MA | DO | P,CEO | P | 123 | 9.46 | 0 | 13 | New | 13 | D | ||||||||||||||
9/8/17 16:40 | 9/6/17 | SCMP | Sucampo Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Meyenburg Jason Patrick | MD | O | Chief Co | P | 49 | 12.13 | 0 | 4 | 15 | 30 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |